Skip to content
SentinelMarket desk
Switch to dark mode

샤페론

378800KOSDAQView the 제약 sectorTheme Bio & healthcare

2,310KRWMarket close of 10/21 (Wed)

Up +1.76%+40KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)2,300KRWDown -0.43%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
2,270
High
2,380
Low
2,215
Day range
Day range low 2,215 high 2,380, open 2,270, close 2,310, previous close 2,270
Volume
3×10K shares
64.39 million KRW 0.35× the 20-session average

Market close of 10/21 (Wed)

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-15.6B KRWOperating income over the last four quarters -15.6B KRW (loss)Operating income, 8 quarters
  • Daily movenot verifiedOnly 15 daily bars to compare, so not verified
  • Trading valuenot verifiedNot enough 20-session trading value data, so not verified

The other 3

  • Recent filingsnot verified
  • Foreign & institutionalnot verified
  • Data date10/21 (Wed)Market close
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue41.17 million KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned profitable
    vs. prior quarter
    -37.0%
  • Operating income-3.1B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Still a loss
    vs. prior quarter
    Still a loss
  • Operating margin-7,565.0%Operating margin bars for the last 6 quarters; the dark bar is this quarter
    vs. year ago
    —
    vs. prior quarter
    -1,957.2 pp

Quarterly operating income trend

As of the latest official close · 2026-10-21Valuation filing date · 2026-08-12
2023Q3 -2.6B KRW2026Q2 -3.1B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Up +0.83%

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +1.5%Up +1.87%166.1B KRW
셀트리온Close over the last 20 sessions +9.6%Up +0.10%119.2B KRW
지투지바이오Close over the last 20 sessions +27.6%Up +13.78%49.8B KRW
삼익제약Close over the last 20 sessions -20.3%Up +2.58%47.2B KRW
유한양행Close over the last 20 sessions +11.7%Up +0.46%35.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 24 days
  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.